Clinical Trial Update: Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations [EARLY_Phase 1]

View source ↗

Summary

The PARTIST trial evaluating personalized adaptive radiation therapy with individualized systemic targeted therapy for locally advanced non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Non-Small Cell Lung Cancer | EARLY_Phase 1 | Status: WITHDRAWN